1-4 of 4
Jeremy Parker, PhD
Close
Sort by
Journal Articles

Outcomes of Patients with Low Variant Allele Fraction JAK2V617F : A 5-Year Retrospective Analysis

Wasithep Limvorapitak, MD, Jeremy Parker, PhD, Lynda Foltz, MD FRCPC, Aly Karsan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4286.
https://doi.org/10.1182/blood-2018-99-111592
Published: 2018
Journal Articles

Resistance to Lenalidomide in Del(5q) MDS Is Mediated By Inhibition of Drug-Induced Megakaryocytic Differentiation

Sergio Martinez-Høyer, PhD, Angela Mo, Deborah Deng, Jihong Jiang, Rod Docking, MSc, Jenny Li, Simon Chan, Patricia Umlandt, Megan Fuller, Martin Jädersten, Eva Hellström-Lindberg, MD PhD, Uwe Platzbecker, Jeremy Parker, PhD, Aly Karsan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 176.
https://doi.org/10.1182/blood-2018-176
Published: 2018
Journal Articles

Single Cell-Resolution Analysis of HSC Dysfunction in Mir-146a knockout Mice

Jennifer Grants, PhD, Joanna Wegrzyn, PhD, David Knapp, PhD, Tony Hui, Kieran O'Neill, PhD, Jeremy Parker, PhD, Deborah Deng, Mark Boldin, PhD, Martin Hirst, PhD, Connie J. Eaves, PhD, Aly Karsan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 714.
https://doi.org/10.1182/blood.V130.Suppl_1.714.714
Published: 2017
Journal Articles

Mechanisms of Resistance to Lenalidomide in Del(5q) Myelodysplastic Syndrome Patients

Sergio Martinez-Høyer, PhD, Rod Docking, PhD, Simon Chan, Martin Jadersten, MDPhD, Jeremy Parker, PhD, Aly Karsan, MD
Journal: Blood
Blood (2015) 126 (23): 5228.
https://doi.org/10.1182/blood.V126.23.5228.5228
Published: 2015